KVUE logo

Kenvue (KVUE) Company Overview

Profile

Full Name:

Kenvue Inc.

Country:

United States

IPO:

May 4, 2023

Indexes:

Description:

Kenvue is a consumer health company that focuses on personal care products, over-the-counter medicines, and wellness solutions. It offers well-known brands like Tylenol and Neutrogena, aiming to improve everyday health and well-being for people around the world. Kenvue emphasizes quality, safety, and innovation in its products.

Key Details

Price

$23.40

Annual Revenue

$15.46 B(+0.07% YoY)

Annual EPS

$0.54(-40.00% YoY)

Beta

0.15

Events Calendar

Earnings

Next earnings date:

May 7, 2025

Recent quarterly earnings:

Feb 6, 2025

Recent annual earnings:

Feb 6, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Feb 12, 2025
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 7, 25 UBS
Neutral
Feb 7, 25 Canaccord Genuity
Buy
Feb 3, 25 RBC Capital
Sector Perform
Jan 17, 25 Barclays
Equal-Weight
Jan 16, 25 UBS
Neutral
Jan 15, 25 Citigroup
Neutral
Jan 6, 25 Piper Sandler
Overweight
Dec 13, 24 Barclays
Equal-Weight
Dec 12, 24 Deutsche Bank
Hold
Oct 22, 24 B of A Securities
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Dividend per share

Dividend yield

Other

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Kenvue?
  • Does Kenvue pay dividends?
  • What sector is Kenvue in?
  • What industry is Kenvue in?
  • What country is Kenvue based in?
  • When did Kenvue go public?
  • Is Kenvue in the S&P 500?
  • Is Kenvue in the NASDAQ 100?
  • Is Kenvue in the Dow Jones?
  • When was Kenvue's last earnings report?
  • When does Kenvue report earnings?
  • Should I buy Kenvue stock now?

What is the ticker symbol for Kenvue?

The ticker symbol for Kenvue is NYSE:KVUE

Does Kenvue pay dividends?

Yes, Kenvue pays dividends. The last payment was $0.20, with an ex-dividend date on February 12, 2025

What sector is Kenvue in?

Kenvue is in the Consumer Defensive sector

What industry is Kenvue in?

Kenvue is in the Household & Personal Products industry

What country is Kenvue based in?

Kenvue is headquartered in United States

When did Kenvue go public?

Kenvue's initial public offering (IPO) was on May 4, 2023

Is Kenvue in the S&P 500?

Yes, Kenvue is included in the S&P 500 index

Is Kenvue in the NASDAQ 100?

No, Kenvue is not included in the NASDAQ 100 index

Is Kenvue in the Dow Jones?

No, Kenvue is not included in the Dow Jones index

When was Kenvue's last earnings report?

Kenvue's most recent earnings report was on Feb 6, 2025

When does Kenvue report earnings?

The next expected earnings date for Kenvue is May 7, 2025

Should I buy Kenvue stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions